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Abstract
Recent studies have indicated that activation of A rA -receptors may mediate metabolic adaptation of the heart to1 2
 . 6  .ischemiarreperfusion stress. This study tests whether pretreatment with A -selective agonist R y -N - 2-phenylisopropyl1
 .  .adenosine R-PIA might mimic effects of a brief period of coronary occlusion ischemic preconditioning, IP on energy
 P.metabolism and hydroxyl radical OH formation in canine myocardium following subsequent prolonged ischemia and
reperfusion. Anaesthetized dogs were randomized to a control group subjected to 40-min occlusion of a diagonal branch of
 .  .left anterior descending coronary artery LAD followed by 1-h reperfusion, or a preconditioned group PC in which the
same period of sustained ischemia and reperfusion was preceded by a single cycle of IP 5-min occlusion of the same LAD
. branch and 10-min reperfusion , or to PIA group in which R-PIA infusion into the same branch of LAD 0.4 mgrkg per
.min during 5 min was followed by 10 min of perfusion prior to sustained ischemia-reperfusion. Pretreatment with R-PIA
 .  .  .similarly to IP reduced lactate Lac , creatine Cr and inorganic phosphate P release from myocytes into the interstitiali
fluid during sustained ischemia compared to these indices in control. By the end of reperfusion, both IP and R-PIA infusion
 .  .enhanced recovery of myocardial ATP and phosphocreatine PCr and attenuated the total creatine SCrsPCrqCr loss,
an index of cell membrane damage. A - receptor activation by R-PIA, as IP, led to a significant reduction in OHP radical1
X  .generation following reperfusion assessed by a spin trap 5,5 -dimethyl-1-pyrroline-N-oxide DMPO using cardiac micro-
 .dialysis. R-PIA pretreatment did not affect systemic and cardiac hemodynamic parameters. We conclude that 1 adaptive
 .mechanisms of IP involve A -receptor activation that contributes to the overall metabolic response and 2 R-PIA acts as a1
useful preconditioning-mimetic and anti-ischemic agent in dogs. q 1997 Elsevier Science B.V.
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1. Introduction
A brief period of coronary occlusion followed by
reperfusion permits the heart to be resistant to subse-
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quent, more severe, ischemiarreperfusion stress. This
 .phenomenon, termed ischemic preconditioning IP ,
has been proved in a variety of animal species,
w xincluding large mammals 1 , and humans undergoing
w xcardiac surgery 2 . Protection afforded by IP is not
only connected with infarct size limitation but also
with enhanced recovery of cardiac contractile func-
0925-4439r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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w xtion and anti-arrhythmic activity 3,4 . Mechanisms
underlying these effects are not clearly understood at
present, though a number of studies indicate an in-
volvement of the adenosine A receptor as both a1
w xtrigger and a mediator of such protection 5 . Re-
cently we showed that preconditioning in the dog was
accompanied by sparing of high energy phosphates
 .HEP following sustained ischemia contributing to
enhanced recovery of oxidative metabolism and re-
duction of contractile dysfunction during reperfusion.
Abolishing of these effects by pretreatment with
adenosine A rA receptor antagonist theophylline1 2
supports the concept that changes in metabolism in-
duced by adenosine receptor activation enhance the
w xischemic tolerance of myocardial cells 6 . However,
the link between A -receptor activation and metabolic1
alterations in preconditioned myocardium has not
been yet investigated. The main aim of the present
work was to determine whether a selective adenosine
receptor agonist R-PIA may induce changes in my-
ocardial metabolism similar to preconditioning in the
same dog model and, thus to exert pharmacological
protection. We have chosen the A selective non-1
metabolisable adenosine analogue, R-PIA, among
other adenosine agonists, because of its high selectiv-
ity and since its preconditioning-mimetic effects have
been well reproduced in a broad range of species
w x2,7–9 .
The other purpose of this study was to assess a
formation of oxygen free radicals in the precondi-
tioned myocardium and effect of A receptor activa-1
tion on their generation. Free radical species gener-
 .ated during reperfusion after short episode s of pre-
conditioned ischemia oxidize many cellular compo-
nents and may be potent inhibitors of energy consum-
ing enzymes, such as ATPases, and thus responsible
for a reduced energy utilization in the preconditioned
w xheart. 10,11 . The hypothesis that free radicals are
implicated in preconditioning has been substantiated
by the fact that pretreatment with radical scavengers
w xeliminates protective effects of IP 10,12 . On the
other hand, IP may reduce reperfusion-induced free
radical production due to attenuation of ATP break-
down, and catecholamine oxidation or enhanced an-
w xtioxidant enzyme activity 13 . Despite abundance of
studies with various adenosine receptor agonists it is
still unknown whether they are capable to affect
oxygen radical formation. Therefore, throughout all
protocols we also examined oxy-radical formation by
spin-trapping and microdialysis technique.
2. Materials and methods
2.1. Animal preparation
Adult mongrel dogs of either sex weighing 15–20
w xkg were prepared as described previously 6 . In
brief, the animals were lightly sedated with droperi-
 .dol 1 mgrkg s.c. , anaesthetized with intravenous
 .sodium thiopental 30 mgrkg i.v. , intubated and
artificially ventilated with room air enriched with
oxygen at 3–4 lrmin. Right internal jugular vein was
 .cannulated for administration of heparin 5000 IU to
prevent thrombus formation and to give small doses
of sodium thiopental as necessary. A catheter was
introduced through the right carotid artery into the
left ventricular cavity for measurement of the left
 .ventricular pressure, its first derivative d Prd t and
heart rate. All indices were recorded on a Siemens
 .Elema 8-channel recorder Mingograph 804 . Left
thoracotomy was performed at the 5th intercostal
space, pericardium was incised and the heart was
suspended in pericardial cradle. The proximal LAD
 .below the second branch or one of its diagonal
branches was isolated, and loose ligature was placed
around it. Blood samples were collected from the left
ventricular cavity through a catheter introduced
through the right carotid artery every 10–15 min to
measure pH, pCO and pO using an acid-base ana-2 2
 .lyzer ABL-30 Radiometer, Copenhagen . These pa-
rameters were maintained within the normal ranges
by injecting sodium bicarbonate to correct metabolic
acidosis, or by adjusting tidal volume and O supple-2
mentation to correct respiratory acidosis.
2.2. Cardiac microdialysis
Three microdialysis probes were implanted in the
area perfused by LAD to be occluded with epicardial
.cyanosis and one was inserted into intact LV wall,
w xusing techniques described previously 14 . Each
probe consisted of a single, dialysis fibre 250 mm
.o.d., 20 mm length, molecular weight cut off 5000
was fixed mid-wall approximately at the depth of 2
mm by means of inflow and outflow silica tubes.
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After implantation, the inflow silica tubes of each
probe were connected to a glass syringe of a
CMAr100 micro-injection pump Carnegye
.  .Medicine . To assess the interstitial lactate Lac ,
 .  .creatine Cr and inorganic phosphate P the syringei
was filled with a modified Krebs-Henseleit solution
 .containing in mmol : NaCl, 118; KCl, 4.7; CaCl ,2
2.3; Na EDTA, 0.5; MgSO , 1.2; KH PO , 1.2 and2 4 2 4
 .buffered with 25 mM N- 2-hydroxyethyl piperazine-
X  .N -2-ethane sulfonic acid Hepes ; pH of the solution
was 7.4"0.1 at 378C. Before use, the solution was
passed through a Millipore filter with a pore size of 5
mm. The same solution containing a spin trap, 100
X  .mM 5,5 -dimethyl-1-pyrroline-N-oxide DMPO , was
used to detect oxygen radicals according to the previ-
w xously described technique 15 . Each probe was per-
fused at a constant flow rate of 3 mlrmin. 40 min
after the beginning of the perfusion, the effluent
referred to as the dialysate, was collected every 10
 .or 20 min from the outflow tube in small plastic
tubes, frozen in liquid nitrogen, and stored until
metabolite analysis and EPR spectra registration. Dif-
fusion occurring between the solution within the fibre
and the interstitial fluid allows to use the dialysate
concentrations of metabolites or radical adducts as
w xindices reflecting their interstitial concentrations 16 .
In the separate series of in vitro experiments we
found that average dialysis recovery within the
physiological concentrations of metabolites 0.5–5.0
.mM were 28.6"2.4, 46.5"3.1 and 33.6"2.8%
w xfor Lac, Cr and P , respectively 6 .i
2.3. Experimental protocol
42 dogs were randomized into three groups: con-
 .trol, preconditioned PC and treated with R-PIA
 .prior to sustained ischemia PIA . After isolation of
LAD branch and implantation of microdialysis probes,
all groups underwent 40-min baseline period for sta-
bilization of hemodynamic variables and collection of
the initial dialysate samples. In control group there
was an additional period of 15-min control perfusion
before ischemia-reperfusion instead of IP. In PC
group, ischemic preconditioning was achieved using
a single 5-min occlusion of LAD branch followed by
10-min reperfusion. In the PIA group, intracoronary
infusion of R-PIA directly into the same branch of
LAD at the rate of 0.4 mgrkg body wtrmin during 5
min followed by a 10-min period of normal perfusion
was applied to mimic IP. This dose of R-PIA was
selected as the highest one in which no hemodynami-
cal effects were observed; it was recently used by
w xGrover et al. to reduce infarct size in dogs 8 .
Animals in all groups were then subjected to 40-min
occlusion of LAD branch and 60-min reperfusion.
During short-time and sustained occlusion, the liga-
ture around the coronary artery was tightened to
produce a zone of regional left ventricular ischemia,
which was confirmed by cyanosis.
At the end of each experimental period, hemody-
namic parameters were recorded. No significant dif-
ferences in systemic and cardiac hemodynamic data
were found between the groups during the entire
experiment. To ensure that all animals used for
metabolic studies were exposed to a similar extent of
ischemia, we excluded dogs with the absence of
epicardial cyanosis during PC and sustained occlu-
sion of LAD branch. For all protocols, dogs that
developed ventricular fibrillation were not resusci-
tated. Three dogs were excluded from the study
because of fibrillation and the absence of cyanosis
according to this criteria.
2.4. Tissue sampling and metabolite assays
Transmural myocardial biopsies from the center of
ischemic zone were taken after the period of control
 .perfusion before sustained ischemia baseline and at
the end of the final reperfusion. A modified disposi-
ble biopsy needles were used allowing to obtain
tissue samples weighing 50–60 mg. All tissue speci-
mens were immediately frozen in liquid nitrogen
until biochemical analysis. The frozen tissue samples
were homogenized in a cooled 6% HClO 10 mlrg4
. frozen tissue with a Polytron homogenizer Brink-
.man Instruments, Westbury, New York . Then they
were allowed to extract for 20 min and centrifuged at
3000=g for 10 min at 48C. The supernatants were
neutralized with 5 M K CO to pH 7.4, centrifuged2 3
at 48C to remove the KClO precipitate and were4
stored frozen before use. Tissue dry weights were
determined by weighing the portion of pellets after
extraction with HClO and drying overnight at 1108C.4
Concentrations of ATP, PCr, Cr and Lac in neu-
tralized tissue extracts were measured spectrophoto-
w xmetrically by enzymatic methods 17 . Modified spec-
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trophotometric micro-methods were used to assay
w xdialysate samples for Lac, Cr and P 6 .i
2.5. Spin-trap detection of free radicals
 .A Varian E-109 E X-band electron spin reso-
 .nance spectrometer Germany was used for registra-
w xtion of EPR spectra of dialysates 15 . EPR signals of
DMPO spin adducts were recorded at room tempera-
ture with a magnetic field modulation of 0.1 mT,
modulation of frequency of 100 kHz, microwave
power of 10 mW, and microwave frequency of 9.15
GHz. Absolute values of DMPO spin adducts concen-
trations were determined as described previously us-
ing a standard solution of the spin label TEMPO
 .2,2,6,6,-tetramethyl-piperidine-N-oxyl .
2.6. Chemicals and drugs
 . 6  .R-PIA, R y -N - 2-phenylisopropyl adenosine,
and reagents for metabolite analyses were purchased
 .from Sigma Chemical Co., St. Louis, MO USA .
The enzymes were obtained from Boehringer-Man-
 .nheim Germany . Buffer solutions for metabolite
assays and microdialysis were prepared using deion-
 .ized water Mili Ro4-Mili-Q, USA .
R-PIA was dissolved in saline and passed through
 .a Millipore filter pore sizes0.22 mm before the
intracoronary infusion. In pilot studies, we found that
a vehicle given intracoronary did not affect hemody-
namics.
2.7. Statistical analysis
Data are reported as means"SEM. Differences
between groups in cardiac hemodynamics and
metabolite contents were evaluated by a two-factor
ANOVA with repeated measures and followed by the
Student-Newman-Keuls multiple comparison method.
A value of P-0.05 was considered to be significant.
3. Results
3.1. Cardiac hemodynamics and metabolic state of
nonischemic area
No significant differences in the left ventricular
 .  .systolic pressure LVSP , heart rate HR , an index of
cardiac contractile function evaluated by LVSP-HR
product, and the maximum rate of rise or fall of left
ventricular pressure development qd Prd t or
Table 1
Systemic and cardiac hemodynamic data
y3 y3 y3Time period LVSP HR LVSP HRP10 qdPrdt maxP10 ydPrdt maxP10
 .  .  .  .  .mm Hg beatsrmin mm Hg beatsrmin mm Hgrs mm Hgrs
 .Control group ns12
Baseline 110"6 142"7 16.0"1.5 2.0"0.1 1.4"0.1
15-min control perfusion 109"7 145"6 15.8"1.4 2.1"0.1 1.3"0.2
40-min sustained ischemia 108"8 146"6 15.8"1.6 2.2"0.1 1.4"0.2
60-min reperfusion 107"7 140"8 15.1"2.3 2.1"0.2 1.6"0.2
 .PC group ns14
Baseline 104"6 152"9 15.8"1.3 2.1"0.2 1.6"0.1
Preconditioning 100"5 152"10 15.2"1.2 1.9"0.1 1.6"0.1
40-min sustained ischemia 104"8 158"10 16.4"1.4 1.7"0.2 1.8"0.2
60-min reperfusion 114"13 156"8 17.7"1.4 1.6"0.2 1.9"0.1
 .PIA group ns14
Baseline 111"7 148"6 16.4"1.1 2.0"0.1 1.5"0.2
R-PIA infusion 110"7 153"10 16.8"1.5 2.1"0.2 1.6"0.2
40-min sustained ischemia 112"8 148"8 16.6"2.0 1.7"0.2 1.5"0.1
60-min reperfusion 120"8 149"9 17.5"1.0 1.8"0.2 1.6"0.2
Values are the means"SEM. LVSP, left ventricular systolic pressure; HR, heart rate; LVSP.HR, left ventricular systolic pressure-heart
 .  .rate product; q or ydPrdt max., the maximal rate of rise q or fall y of LVSP. Data were obtained during baseline period; at the
end of control perfusion; 10 min after R-PIA infusion; at the end of IP, sustained occlusion of LAD branch and the final reperfusion.
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.yd Prd t, respectively were found between the
 .groups during the entire experiment Table 1 . After
the final reperfusion, tissue levels of high-energy
phosphates, Cr, SCr and Lac in nonischemic area did
Table 2
Effects of IP and R-PIA pretreatment on myocardial contents of
metabolites in nonischemic and ischemic area
Control group PC group PIA group
ATP
Nonischemic area
Baseline 24.7"1.2 25.4"1.3 23.9"1.3
Reperfusion 22.2"2.3 24.6"1.8 21.4"1.9
Ischemic area
Baseline 25.9"0.9 26.1"0.9 27.9"1.1
b a,b abReperfusion 11.2"1.1 15.6"1.2 15.0"1.5
PCr
Nonischemic area
Baseline 31.9"2.3 32.8"1.8 30.4"2.0
Reperfusion 29.9"1.3 30.7"2.3 31.3"2.4
Ischemic area
Baseline 30.4"2.5 32.1"1.8 29.4"2.0
b ab bReperfusion 14.0"1.3 18.8"1.4 19.3"2.4
Cr
Nonischemic area
Baseline 64.0"3.2 63.7"3.4 61.5"2.9
Reperfusion 60.3"3.9 62.6"4.1 62.5"3.8
Ischemic area
Baseline 64.8"3.4 66.0"3.7 68.5"3.9
Reperfusion 56.3"3.6 64.6"4.0 62.5"3.8
SCr
Nonischemic area
Baseline 95.8"3.4 96.4"3.3 92.1"2.7
Reperfusion 92.1"2.8 93.4"3.8 91.7"3.1
Ischemic area
Baseline 95.3"3.1 98.1"3.5 97.8"3.6
ab ab abReperfusion 70.1"2.8 83.4"3.6 81.9"3.0
Lac
Nonischemic area
Baseline 11.4"0.8 12.1"1.0 10.7"1.3
Reperfusion 12.9"1.2 12.0"0.9 11.8"2.0
Ischemic area
Baseline 12.3"0.9 12.6"1.0 11.9"1.6
b aReperfusion 16.9"1.2 13.2"1.2 14.8"2.5
Values are the means"SEM for 12–14 experiments and ex-
pressed in mmolrg dry weight. Transmural biopsies were taken
 .after the period of control perfusion baseline and at the end of
the final reperfusion. In PC group, a 5-min occlusion of LAD
branch followed by a 10-min reperfusion was applied prior to
sustained ischemia. R-PIA intracoronary infusion 0.4
.mgrkgrmin for 5 min followed by 10 min of normal perfusion
before sustained ischemia was used to mimic IP. SCrsPCrqCr.
 . a bSignificant difference P -0.05 from: - control; - baseline.
 .not differ from the initial ones Table 2 . In nonis-
chemic area dialysate Cr, Lact and P concentrationsi
did not change throughout the experiment remaining
 .very close to the baseline levels Figs. 1–3 . These
data mean that the animals remained hemodynami-
cally stable, and adequate aerobic metabolism was
persisted in nonischemic myocardium throughout all
protocols.
3.2. Metabolism of ischemic area
A partial depletion of high energy phosphates in-
duced by IP was accompanied by a rise in P and Cri
concentrations in dialysate collected for this period
compared to these indices for nonpreconditioned my-
 .ocardium Figs. 1 and 2 . In contrast, treatment with
R-PIA did not change significantly dialysate concen-
trations of both catabolites at the end of normal
perfusion. PC and PIA groups showed a reduced
accumulation of P and Cr in the interstitial fluidi
following sustained ischemia compared to the control
group. In all groups, dialysate Cr and P concentra-i
tions decreased during reperfusion to the initial lev-
els. After reperfusion, myocardial contents of PCr,
ATP and SCr — an index of membrane integrity —
were higher in PC and PIA groups than in control
 .Table 2 .
Lac concentration in dialysate was increased after
a brief period of LAD occlusion in PC group, but did
not differ significantly from baseline value in PIA
 .group prior to sustained ischemia Fig. 3 . Though
the significant difference in dialysate Lac between
the control and two other groups was found only at
the 20th min of sustained ischemia, PC and PIA
groups exhibited a clear tendency to less Lac accu-
mulation in the interstitial fluid throughout the period
of prolonged LAD occlusion. Following reperfusion,
dialysate Lac returned more rapidly to the baseline
level in PC group than in two others. At the end of
reperfusion, myocardial Lac did not differ from the
initial one in PC and PIA groups and remained
 .significantly higher in control Table 2 .
3.3. Oxygen radical formation
EPR spectra of DMPO-containing dialysates pre-
dominantly consisted of four equidistant components
with the ratio of intensities 1:2:2:1, thus indicating
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Fig. 1. Time course of changes in dialysate P in the region ofi
LAD occlusion. Values are the means"SEM of 12–14 experi-
ments. Open circles - the control group; closed circles - PC
group; closed rhombes - PIA group; open triangeles - the baseline
level in the intact area. Shaded areas indicate ischemic period.
 . ) qSignificant difference P -0.05 : control vs. PC; PIA vs.
control.
Fig. 2. Effects of IP and R-PIA pretreatment on time course of
changes in dialysate Cr concentration in the region of LAD
occlusion. Values are the means"SEM of 12–14 experiments.
Open circles - the control group; closed circles - PC group;
closed rhombes - PIA group; open triangles - the baseline level in
the intact area. Shaded areas indicate ischemic period. Significant
 . ) qdifference P -0.05 : control vs. PC; PIA vs. control.
Fig. 3. Dialysate Lac profiles in the region of LAD occlusion.
Values are the means"SEM of 12–14 experiments. Open circles
- the control group; closed circles - PC group; closed rhombes -
PIA group; open triangles - the baseline level in the intact area.
Shaded areas indicate ischemic period. Significant difference
 . ) qP -0.05 : control vs. PC; PIA vs. control.
Fig. 4. Effects of IP and R-PIA pretreatment on time course of
 .dialysate concentration of hydroxyl radical adduct DMPO-OH
in the region of LAD occlusion. Values are the means"SEM of
6 experiments. Open circles - the control group; closed circles -
PC group; closed rhombes - PIA group. Shaded areas indicate
 . )ischemic period. Significant difference P -0.05 : control vs.
PC; q PIA vs. control.
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the presence of hydroxyl radical spin adduct —
DMPO-OH which could arise from direct trapping of
OHP radicals as well as from a breakdown of rather
w xunstable superoxide radical adduct 15,18 . The con-
trol group showed a progressive rise of dialysate
DMPO-OH concentration following ischemia which
reached its maximal value at the beginning of reper-
fusion and did not change significantly further Fig.
.4 . The cycle of IP markedly increased DMPO-OH
signal in dialysate collected for this period and de-
creased DMPO-OH formation during the final reper-
fusion compared to that in control. The DMPO-OH
signals in dialysates from R-PIA treated myocardium
showed a similar time course and did not differ from
those ones in PC group except for the absence of
enhanced DMPO-OH formation before sustained is-
chemia.
4. Discussion
The results of the present study are the first to
clearly demonstrate that A -receptor activation by1
R-PIA is capable to mimic metabolic effects of IP in
the dog. They are manifested in reduced Cr, P andi
Lac accumulation in cardiomyocytes during sustained
ischemia reflecting attenuation of HEP and glycogen
 .depletion Figs. 1–3 . During reperfusion, the my-
ocardium pretreated with R-PIA shows enhanced re-
covery of ATP and PCr, and less cell membrane
damage which are similar to those ones in the pre-
 .conditioned tissue Table 1 . Another interesting as-
pect is that A -activation, as IP, leads to a reduction1
in oxygen radical formation following reperfusion
 .Fig. 4 . Presently, the mechanisms of metabolic and
antioxidant protection afforded by R-PIA are un-
known, though some suggestions may be based on
recent studies.
There is a growing body of evidence that activa-
tion of A -receptors by R-PIA, 2-chloro-N 6-cyclo-1
 . 6pentyladenosine CCPA , N -cyclohexyladenosine
 .  . wCHA or 2-amino-4,5-dimethyl-3-thienyl - 3-triflu-
x  .oromethylphenyl methanone PD 81,723 mimics,
while blockade of these receptors by the A selective1
antagonist 8-cyclopentyl-1,3-dipropylxanthine
 .CPDPX abolishes cardioprotective effects of IP
w x5,8,19–21 . Activation of A -receptors, in turn, leads1
w xto an increase in K channel activity 22 , whileATP
administration of selective K channel blockers,ATP
 .glibenclamide or 5-hydroxydecanoate 5-HD , pre-
w xvents anti-infarct effects of IP and R-PIA 8,21 .
Taken together, these findings indicate that in several
species, including dogs, both IP and R-PIA may
protect ischemic myocardium via stimulating KATP
channel-related mechanisms. Probably, the most prin-
cipal one is a shortening of action potential duration
resulting in a decrease in inward Ca2q current through
voltage dependent Ca2q channels and slowing down
w xcellular metabolism 23 . Indeed, the majority of
studies demonstrate that successful IP is associated
with a reduction in energy utilization and the rate of
glycolysisrglycogenolysis following the prolonged
ischemic period. As a rule, the resultant reduction in
HEP depletion and less accumulation of toxic cellular
catabolites facilitate recovery of oxidative phosphory-
lation and attenuate tissue injury during reperfusion
ww x x24 for referemce . Further delineation of metabolic
basis of IP required exploration of selective agonists
and antagonists of adenosine receptors. Our previous
study revealed that elimination of enhanced cellular
energy state and integrity of cell membranes in pre-
conditioned canine myocardium pretreated with
adenosine A rA receptor antagonist theophylline1 2
are likely associated with a blockade of myocardial
w xuptake and utilization of glucose during ischemia 6 .
The subtype of receptor responsible for these
metabolic alterations remained unknown because of
the nonselectivity of antagonist. The results of the
present work demonstrate that similar metabolic
changes in ischemic and reperfused myocardium can
be induced by pretreatment with selective adenosine
agonist R-PIA. They support the concept that activa-
tion of A -receptors mimics metabolic effects of IP1
via downregulation of catabolism in ischemic tissue
 .Figs. 1–3 and stimulation of myocardial energy
 .production during reperfusion Table 1 . Augmented
energy stores combined with decreased radical forma-
tion may contribute to membrane salvage and cellular
survival, thus being the basis on which IP and R-PIA
w xreduce infarct size 8 . Though relations between
alterations of myocardial levels of high energy phos-
phates, intracellular acidosis and catabolite accumula-
tion on the one hand, and postischemic functional
recovery or tissue injury on the other hand, vary
depending on experimental model, we believe that
energy sparing is an important component of the
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protection of preconditioned hearts as well as nonpre-
w xconditioned ones 25 .
At the same time there are some arguments against
the involvement of A -receptors and K channel1 ATP
activity in mediating metabolic adaptation induced by
IP. First, it is a failure of a highly specific A -recep-1
tor antagonist CPDPX to antagonize the cardioprotec-
w xtive effect of IP in some cases 26 . This apparent
discrepancy may be explained by features of experi-
mental model or antagonist concentration used. Sec-
ond, not all studies confirmed that a blockade of
K channels abolishes the protection afforded byATP
w xadenosine antagonists 27 . Third, because of the
similarity between A and the newly cloned A1 3
w xreceptor 28 , it may be that some metabolic alter-
ations ascribed to the A -receptor activation are actu-1
w xally mediated by the A receptor 29 . The involve-3
ment of A receptor has been confirmed by studies3
showing that the selective antagonist for this particu-
 .lar receptor 1,3-dipropyl-8- 4-carboxyethenylphenyl
 .xanthine BWA1433 attenuates the IP-induced pro-
w xtection in isolated hearts and myocytes 30,31 .
Therefore, a link between the transduction pathways
associated with A -receptor activation and the overall1
metabolic response of postischemic myocardium still
needs to be elucidated.
Our data are consistent with observations showing
that oxygen radical generation during IP may protect
the heart against reperfusion injury induced by oxi-
w xdant stress 10,13 . This is testified by a decreased
production of OHP radicals in the preconditioned
 .myocardium during reperfusion Fig. 4 . The most
intriguing finding is that the same effect on OHP
radical production is induced by preischemic R-PIA
administration. It is unclear, how a slight oxygen
radical generation during IP or A -receptor activation1
might elicit compensatory antioxidant reserve of
postischemic myocardium. The well-accepted sources
of reactive oxygen species during ischemia and reper-
fusion include oxidation of catecholamines,
metabolism of prostaglandins and leukotrienes, oxida-
tion of xanthine and hypoxanthine to uric acid, and
the uncoupling of the mitochondrial electron trans-
w xport chain 32 . Theoretically, adenosine formation
during a brief period of IP is capable to attenuate
norepinephrine release from sympathetic nerves dur-
w xing sustained ischemia 33 and to antagonize the
positive inotropic effect of catecholamines mediated
w xvia adenylate cyclase system 34 . These effects would
compromise myocardial oxygen demand, decrease
the rate of ATP degradation and limit the uncoupling
of the respiratory chain. IP can also reduce the vascu-
lar production of oxygen-derived free radicals via
limitation of ischemia-induced, Ca2q-dependent con-
version of xanthine dehydrogenase to xanthine oxi-
dase, i.e. through preventing increase of intracellular
2q w xCa 35 , and attenuation of neutrophil accumula-
w xtion during reperfusion 36 . Additionally, the intra-
cellular mechanisms of IP mediated by adenosine
involves the transcription of mRNA and subsequent
synthesis of certain protective proteins, including an-
w xtioxidant proteins 13,37 . Examination of antioxidant
defense systems in the preconditioned heart and iso-
lated myocytes of different animal species revealed
the increased activity in mitochondrial manganese-su-
 . w xperoxide dismutase Mn-SOD 38,39 and catalase
w x37 . Thus it is very likely that some of these mecha-
nisms could be realized through A -receptor activa-1
tion by intracoronary infusion of R-PIA prior to
sustained ischemia.
Finally, the results presented in this paper extend a
notion on mechanisms of R-PIA action as a useful
anti-ischemic agent. We believe that they could have
some clinical implications, since to date a number of
patient groups have been identified in which signs of
metabolic adaptation have been demonstrated after
atrial pacing stress, percutaneous transluminal coro-
nary angioplasty and aortic cross-clamping during
w xcardiac surgery 40 . Further insight into the mecha-
nisms of IP could potentially help to develop phar-
macological agents which mimic preconditioning
thereby adapting the heart to subsequent
ischemiarreperfusion stress.
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